Clinical trial
Radiofrequency Ablation in Treating Patients With Bone Metastases
NCT00026247 · American College of Radiology Imaging Network, Other · Completed
Key facts
| NCT number | NCT00026247 |
|---|---|
| Title | Radiofrequency Ablation in Treating Patients With Bone Metastases |
| Official title | A Phase I/II Study of Percutaneous Radiofrequency Ablation of Bone Metastases Using CT Guidance |
| Acronym | ACRIN-6661 |
| Lead sponsor | American College of Radiology Imaging Network, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Study type | Interventional |
| Conditions | Metastatic Cancer, Pain, Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Procedure |
| Interventions | pain therapy, radiofrequency ablation |
| Enrollment | 66 |
| Start date | Nov 1, 2001 |
| Primary completion | Feb 15, 2010 |
| Completion | Feb 15, 2010 |
| First posted | Jan 27, 2003 |
| Last update posted | Jul 5, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: